Drug Approval | June 09, 2026
FDA expands Pfizer’s HYMPAVZI approval
Broadening access for children & patients with inhibitor-complicated hemophilia
Broadening access for children & patients with inhibitor-complicated hemophilia
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
Seasoned pharmaceutical marketing leader brings extensive experience in brand management, sales strategy, and digital engagement to the expanded leadership role
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies
CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate
Fertility platform launches flagship clinic with advanced IVF tech
Subscribe To Our Newsletter & Stay Updated
